A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.

NCT01299597 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Disorders

Interventions

DRUG: Atorvastatin
DRUG: Simvastatin
DRUG: SB649868

Sponsor

GlaxoSmithKline